TEVA PHARMACDRN financial statements, including revenue, expenses, profit, and loss

The total revenue of T1EV34 for the last quarter is 23.02 B BRL, and it's 20.60% higher compared to the previous quarter. The net income of Q2 24 is -4.67 B BRL.